OrigiMed (至本医疗) Company Profile: Funding, Investors & Partnerships

OrigiMed (至本医疗)

OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, we identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to fortify the evolution of cancer precision medicine in China.OrigiMed is a medical science and technology transforming company which focuses on developing new te Show More

Alpha Score

66.4

Total Funding$ 10.00 M